- Home
- MGLD vs TURN Comparison
MGLD vs TURN Comparison
Compare MGLD & TURN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MGLD
- TURN
- Stock Information
- Founded
- MGLD 1996
- TURN 1981
- Country
- MGLD United States
- TURN United States
- Employees
- MGLD N/A
- TURN N/A
- Industry
- MGLD Finance/Investors Services
- TURN Finance/Investors Services
- Sector
- MGLD Finance
- TURN Finance
- Exchange
- MGLD Nasdaq
- TURN Nasdaq
- Market Cap
- MGLD 36.5M
- TURN 39.9M
- IPO Year
- MGLD N/A
- TURN N/A
- Fundamental
- Price
- MGLD $0.91
- TURN $4.01
- Analyst Decision
- MGLD
- TURN
- Analyst Count
- MGLD 0
- TURN 0
- Target Price
- MGLD N/A
- TURN N/A
- AVG Volume (30 Days)
- MGLD 5.0K
- TURN 30.3K
- Earning Date
- MGLD 05-08-2025
- TURN 06-03-2025
- Dividend Yield
- MGLD N/A
- TURN N/A
- EPS Growth
- MGLD N/A
- TURN N/A
- EPS
- MGLD N/A
- TURN N/A
- Revenue
- MGLD $31,205,000.00
- TURN $194,813.00
- Revenue This Year
- MGLD N/A
- TURN N/A
- Revenue Next Year
- MGLD N/A
- TURN N/A
- P/E Ratio
- MGLD N/A
- TURN N/A
- Revenue Growth
- MGLD N/A
- TURN 254.25
- 52 Week Low
- MGLD $0.70
- TURN $3.12
- 52 Week High
- MGLD $2.10
- TURN $4.25
- Technical
- Relative Strength Index (RSI)
- MGLD 50.13
- TURN 52.49
- Support Level
- MGLD $0.85
- TURN $3.82
- Resistance Level
- MGLD $0.92
- TURN $4.25
- Average True Range (ATR)
- MGLD 0.07
- TURN 0.27
- MACD
- MGLD 0.00
- TURN -0.01
- Stochastic Oscillator
- MGLD 27.40
- TURN 57.02
About MGLD The Marygold Companies Inc.
The Marygold Companies Inc is a holding company that intends to focus on financial services. It is currently directing its investments towards financial services and the emerging Fintech space.
About TURN 180 Degree Capital Corp.
180 Degree Capital Corp is active in the financial services domain. It is a non-diversified closed-end management investment company whose objective is to achieve long-term capital appreciation by making venture capital investments. It focuses its investments on companies commercializing and integrating products enabled by disruptive technologies mainly in the life sciences, precision medicine, and health industries.